Physician profile
David Oakes
NPI 1083642987
$3,712.34
in general payments reported to CMS, 2019-2025
25 companies · $489 in 2025
The $489 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $207 · 2021: $138 · 2022: $347 · 2023: $1,443 · 2024: $465 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $978.14 | 2023-2025 | Optimizer, Optimizer |
| Medtronic, INC. | $367.59 | 2021-2025 | Micra, Linq II |
| Abbott Laboratories | $313.46 | 2019-2025 | Aveir, Cardiomems |
| Boston Scientific Corporation | $293.66 | 2019-2025 | Watchman Access System, Watchman Flx |
| Medtronic Vascular, INC. | $247.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $237.39 | 2019-2024 | |
| Biosense Webster, INC. | $183.07 | 2020-2025 | Carto 3, Qdot Micro Catheter, Na |
| Pfizer INC. | $170.29 | 2021-2024 | |
| Stryker Corporation | $141.22 | 2025 | Flowtriever |
| Atricure, INC. | $126.79 | 2019 | |
| Biotronik INC. | $125.55 | 2023 | Acticor 7 Vr-T Dx |
| Janssen Pharmaceuticals, INC | $107.96 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $93.36 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.65 | 2023-2024 | Jardiance |
| Philips North America LLC | $46.93 | 2023-2025 | Extended Holter |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $39.15 | 2023-2024 | |
| Angiodynamics, INC. | $32.98 | 2023-2024 | Alphavac, Angiovac |
| Cvrx, INC. | $29.00 | 2022 | |
| Itamar Medical INC | $19.07 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.65 | 2023 | Amvuttra |
| Amgen INC. | $15.31 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $13.32 | 2023 | Camzyos |
| Merck Sharp & Dohme LLC | $13.14 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.79 | 2022 | |
| Amarin Pharma, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Oakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.